Ze Hua Zhao
Finanzdirektor/CFO bei UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED
Aktive Positionen von Ze Hua Zhao
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED | Finanzdirektor/CFO | 01.10.2011 | - |
Direktor/Vorstandsmitglied | 16.06.2015 | - | |
Comptroller/Controller/Auditor | 01.01.2005 | 01.10.2011 |
Karriereverlauf von Ze Hua Zhao
Ehemalige bekannte Positionen von Ze Hua Zhao
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Chengde Tianyuan Pharmaceutical Industry Co., Ltd.
Chengde Tianyuan Pharmaceutical Industry Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Goldenmax International Group Ltd., Chengde Tianyuan Pharmaceutical Industry Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical preparations. The company is based in Chengde, China. Chengde Tianyuan Pharmaceutical Industry Co. was acquired by Goldenmax International Group Ltd. on October 23, 2019 for $26.17 million. | Finanzdirektor/CFO | 01.08.1989 | 01.12.2004 |
Ausbildung von Ze Hua Zhao
Hebei Radio & TV University | Undergraduate Degree |
Statistik
International
China | 4 |
Operativ
Director of Finance/CFO | 2 |
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Sektoral
Retail Trade | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED | Retail Trade |
Private Unternehmen | 1 |
---|---|
Chengde Tianyuan Pharmaceutical Industry Co., Ltd.
Chengde Tianyuan Pharmaceutical Industry Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Goldenmax International Group Ltd., Chengde Tianyuan Pharmaceutical Industry Co., Ltd. is a pharmaceutical company that manufactures pharmaceutical preparations. The company is based in Chengde, China. Chengde Tianyuan Pharmaceutical Industry Co. was acquired by Goldenmax International Group Ltd. on October 23, 2019 for $26.17 million. | Health Technology |
- Börse
- Insiders
- Ze Hua Zhao
- Erfahrung